- Home
- WASH vs PHAR Comparison
WASH vs PHAR Comparison
Compare WASH & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- PHAR
- Stock Information
- Founded
- WASH 1800
- PHAR 1988
- Country
- WASH United States
- PHAR Netherlands
- Employees
- WASH N/A
- PHAR N/A
- Industry
- WASH Major Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- PHAR Health Care
- Exchange
- WASH Nasdaq
- PHAR Nasdaq
- Market Cap
- WASH 623.4M
- PHAR 618.3M
- IPO Year
- WASH N/A
- PHAR N/A
- Fundamental
- Price
- WASH $32.52
- PHAR $8.20
- Analyst Decision
- WASH Hold
- PHAR Strong Buy
- Analyst Count
- WASH 2
- PHAR 3
- Target Price
- WASH $34.00
- PHAR $27.00
- AVG Volume (30 Days)
- WASH 205.0K
- PHAR 5.6K
- Earning Date
- WASH 01-29-2025
- PHAR 03-13-2025
- Dividend Yield
- WASH 6.78%
- PHAR N/A
- EPS Growth
- WASH N/A
- PHAR N/A
- EPS
- WASH N/A
- PHAR N/A
- Revenue
- WASH $98,251,000.00
- PHAR $285,745,000.00
- Revenue This Year
- WASH N/A
- PHAR $20.08
- Revenue Next Year
- WASH $10.09
- PHAR $9.22
- P/E Ratio
- WASH N/A
- PHAR N/A
- Revenue Growth
- WASH N/A
- PHAR 30.64
- 52 Week Low
- WASH $24.11
- PHAR $6.65
- 52 Week High
- WASH $40.59
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- WASH 48.04
- PHAR 36.29
- Support Level
- WASH $30.79
- PHAR $8.49
- Resistance Level
- WASH $32.89
- PHAR $9.35
- Average True Range (ATR)
- WASH 0.99
- PHAR 0.55
- MACD
- WASH 0.19
- PHAR -0.17
- Stochastic Oscillator
- WASH 57.22
- PHAR 12.14
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.